Crystalys Therapeutics is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on addressing the significant unmet medical needs of people living with gout. Its lead investigational therapy, dotinurad, is a next-generation, highly selective urate transporter 1 (URAT1) inhibitor designed to lower serum uric acid by targeting the renal transport pathways responsible for urate reabsorption. The company was co-founded by its executive team together with Catalys Pacific and Novo Holdings, and is running Phase 2 and Phase 3 clinical trials (AMETHYST, RUBY and TOPAZ) in the U.S. and Europe to evaluate dotinurad as a second-line therapy for hyperuricemia associated with gout.
Crystalys Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Clinical Stage, Pharmaceuticals, and Drug Development.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/crystalys-therapeutics/"><img src="https://apis.io/badge/crystalys-therapeutics/card.svg" alt="Crystalys Therapeutics on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: crystalys-therapeutics
name: Crystalys Therapeutics
description: Crystalys Therapeutics is a clinical-stage biopharmaceutical company headquartered in San Diego, California,
focused on addressing the significant unmet medical needs of people living with gout. Its lead investigational therapy,
dotinurad, is a next-generation, highly selective urate transporter 1 (URAT1) inhibitor designed to lower serum uric acid
by targeting the renal transport pathways responsible for urate reabsorption. The company was co-founded by its executive
team together with Catalys Pacific and Novo Holdings, and is running Phase 2 and Phase 3 clinical trials (AMETHYST, RUBY
and TOPAZ) in the U.S. and Europe to evaluate dotinurad as a second-line therapy for hyperuricemia associated with gout.
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- security
generated: '2026-11-06'
method: derived
image: https://crystalystx.com/wp-content/uploads/2024/12/crystalys_wordmark_rgb.svg
url: https://raw.githubusercontent.com/api-evangelist/crystalys-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-11-04 (modular-v1; identity re-run after front-door verdict:open)
specificationVersion: '0.20'
created: '2026-10-11'
modified: '2026-11-04'
tags:
- Company
- Biopharmaceutical
- Clinical Stage
- Pharmaceuticals
- Drug Development
- Therapeutics
- Gout
- Hyperuricemia
- Dotinurad
- URAT1 Inhibitor
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://crystalystx.com/
- type: Newsroom
url: https://crystalystx.com/news/
- type: PrivacyPolicy
url: https://crystalystx.com/privacy-policy/
- type: TermsOfService
url: https://crystalystx.com/terms-of-use/
- type: LinkedIn
url: https://www.linkedin.com/company/crystalys-therapeutics/
- type: X
url: https://x.com/Crystalys_Tx
- type: Hosts
url: hosts/crystalys-therapeutics-hosts.yml
- type: Vendors
url: vendors/crystalys-therapeutics-vendors.yml
- type: DomainSecurity
url: security/crystalys-therapeutics-domain-security.yml
apis: []
x-coverage:
state: none
reason: not-a-software-company
detail: Crystalys Therapeutics is a clinical-stage biopharmaceutical company; its own site is a WordPress corporate marketing
site (home, about-us, science, news, investors, contact, legal) with no developer, API, docs or SDK pages, and preflight
contract discovery against crystalystx.com and api.crystalystx.com returned absent for OpenAPI, AsyncAPI, GraphQL and
MCP.
evidence:
- url: https://crystalystx.com/api
status: 404
- url: https://crystalystx.com/developers
status: 404
- url: https://crystalystx.com/docs
status: 404
- url: https://crystalystx.com/developer
status: 404
- url: https://crystalystx.com/sitemap_index.xml
status: 200
checked: '2026-11-04'
x-enrichment:
date: '2026-11-04'
status: nochange
artifacts_added: 0
pass: modular-v1
engine: identity=anthropic,contract=anthropic,surfaces=anthropic,docs=anthropic,regulatory=anthropic
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.